Sample | Title | Value | Rank |
GSM780707 | Untreated after 4 days (C1_1) | 41.1257 | 10 |
GSM780708 | Untreated after 4 days (C2_1) | 43.7373 | 21 |
GSM780709 | Untreated after 4 days (C3_1) | 43.074 | 18 |
GSM780719 | Untreated after 4 days (C1_2) | 40.1866 | 7 |
GSM780720 | Untreated after 4 days (C2_2) | 41.2016 | 10 |
GSM780721 | Untreated after 4 days (C3_2) | 41.8828 | 13 |
GSM780710 | Trastuzumab treated after 4 days (T1_1) | 42.7857 | 16 |
GSM780711 | Trastuzumab treated after 4 days (T2_1) | 43.4672 | 20 |
GSM780712 | Trastuzumab treated after 4 days (T3_1) | 42.9241 | 17 |
GSM780722 | Trastuzumab treated after 4 days (T1_2) | 40.1193 | 7 |
GSM780723 | Trastuzumab treated after 4 days (T2_2) | 43.4851 | 20 |
GSM780724 | Trastuzumab treated after 4 days (T3_2) | 42.7056 | 16 |
GSM780713 | Pertuzumab treated after 4 days (P1_1) | 33.8065 | 1 |
GSM780714 | Pertuzumab treated after 4 days (P2_1) | 44.8148 | 26 |
GSM780715 | Pertuzumab treated after 4 days (P3_1) | 41.202 | 10 |
GSM780725 | Pertuzumab treated after 4 days (P1_2) | 41.5499 | 11 |
GSM780726 | Pertuzumab treated after 4 days (P2_2) | 40.7666 | 9 |
GSM780727 | Pertuzumab treated after 4 days (P3_2) | 40.7823 | 9 |
GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 44.6154 | 25 |
GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 43.3972 | 19 |
GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 37.568 | 2 |
GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 40.7873 | 9 |
GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 40.7281 | 9 |